Rachel Haurwitz

Rachel Haurwitz
Haurwitz in 2019
Born	Rachel Elizabeth Haurwitz (1985-05-20) May 20, 1985 (age 39) Austin, Texas, U.S.
Alma mater	Harvard College (B.A.) University of California, Berkeley (Ph.D.)
Scientific career
Fields	Biochemistry
Institutions	Caribou Biosciences
Thesis	The CRISPR endoribonuclease Csy4 utilizes unusual sequence- and structure-specific mechanisms to recognize and process crRNAs (2012)
Doctoral advisor	Jennifer Doudna

Rachel Elizabeth Haurwitz (born May 20, 1985) is an American biochemist and structural biologist. She is the co-founder, chief executive officer, and president of Caribou Biosciences, a genome editing company.